• China unveils a 20-measure technology insurance program covering the entire innovation lifecycle—from R&D to commercialization—designed to reduce financial risk and accelerate breakthroughs in AI, semiconductors, quantum tech, and other strategically vital sectors.
• The policy targets key industries including artificial intelligence, semiconductors, quantum technologies, hydrogen energy, bio-manufacturing, and brain-computer interfaces, with specialized insurance products and IP protection for overseas expansion.
• China aims to mobilize massive insurance capital pools as “patient capital” for long-term investment in strategic tech projects, potentially channeling billions into deep-tech innovation and intensifying US-China competition in frontier technologies.

China has announced a new national policy designed to expand “technology insurance”—a financial tool aimed at protecting high-risk research, advanced manufacturing, and strategic innovation. The initiative, jointly released by China’s Ministry of Science and Technology, the National Financial Regulatory Administration, the Ministry of Industry and Information Technology, and the National Intellectual Property Administration, seeks to create an insurance framework that supports China’s long-term goal of technological self-reliance.

The policy introduces a 20-measure program to build an insurance system covering the entire innovation lifecycle—from research and development through commercialization and global expansion. The goal is to reduce financial risk for companies developing frontier technologies while encouraging insurers and investors to fund emerging industries.

At its core, the initiative attempts to solve a key problem in advanced technology development: innovation is expensive and risky. By spreading risk across insurers, reinsurance markets, and government support mechanisms, China hopes to accelerate breakthroughs in sectors considered strategically vital.

Several industries receive particular attention. The policy specifically calls for tailored insurance products for artificial intelligence, semiconductors, quantum technologies, hydrogen energy, bio-manufacturing, brain–computer interfaces, and advanced robotics. Insurance firms will be encouraged to develop specialized underwriting models and risk reserves to support these sectors.

The plan also expands protection for intellectual property, including coverage for patent litigation, trademark disputes, and overseas infringement. Chinese firms operating internationally will receive enhanced export credit insurance and risk monitoring systems to support overseas expansion.

Small and mid-sized technology companies are another major focus. The policy calls for simpler and lower-cost insurance products and proposes building insurance service platforms in technology parks, incubators, and high-tech industrial zones. Regional innovation hubs such as Beijing, the Yangtze River Delta, and the Greater Bay Area will serve as test beds for new financial-insurance models.

Perhaps most notable for global investors is the plan to mobilize China’s massive insurance capital pools. Regulators want insurers to act as “patient capital,” investing long-term in strategic technology projects and venture capital funds focused on emerging industries.

If implemented at scale, the policy could channel billions of dollars into China’s advanced technology ecosystem, strengthening state-backed industrial strategies in semiconductors, AI, and other frontier sectors where the United States and China are already competing intensely.

For Western observers, the message is clear: China is building a financial infrastructure designed to systematically absorb the risks of deep-tech innovation, potentially accelerating development timelines in strategically sensitive technologies.

Important Disclaimer: This summary is derived from reporting distributed by Chinese official sources and affiliated industry associations. Because the information originates from state-linked media and government communications, key details should be independently verified through additional sources before being relied upon for business or policy decisions.